Tacrolimus ointment in the management of atopic dermatitis
Authors:
- Antonello BaldoABAntonello Baldo
- Mariana CafieroMCMariana Cafiero
- Di CaterinoDCDi Caterino
- Di CostanzoDCDi Costanzo
Open Access
- 1 January 2009
- journal article
- Published by Taylor & Francis in Clinical, Cosmetic and Investigational Dermatology
- Vol. 2, 1-7
Abstract
Peer reviewed article authored by (Antonello Baldo, Mariana Cafiero, Paola Di Caterino, Luisa Di Costanzo). Read article or submit your manuscript for publishing.Keywords
This publication has 52 references indexed in Scilit:
- The safety of tacrolimus ointment for the treatment of atopic dermatitis: a reviewBritish Journal of Dermatology, 2007
- Safety and Efficacy of Topical Calcineurin Inhibitors in the Treatment of Childhood Atopic DermatitisAmerican Journal of Clinical Dermatology, 2005
- Tacrolimus ointment for the treatment of atopic dermatitis is not associated with an increase in cutaneous infectionsJournal of the American Academy of Dermatology, 2002
- Efficacy and safety of tacrolimus ointment compared with that of hydrocortisone acetate ointment in children with atopic dermatitisJournal of Allergy and Clinical Immunology, 2002
- Tacrolimus and pimecrolimus: From clever prokaryotes to inhibiting calcineurin and treating atopic dermatitisJournal of the American Academy of Dermatology, 2002
- Tacrolimus ointment for the treatment of atopic dermatitis in adult patients: Part II, safetyJournal of the American Academy of Dermatology, 2001
- Itch and Atopic Dermatitis: An OverviewThe Journal of Dermatology, 1999
- The occurrence of atopic dermatitis in North Europe: An international questionnaire studyJournal of the American Academy of Dermatology, 1996
- Genetic risk for asthma, allergic rhinitis, and atopic dermatitis.Archives of Disease in Childhood, 1992
- FK-506, a novel immunosuppressant isolated from a Streptomyces. II. Immunosuppressive effect of FK-506 in vitro.The Journal of Antibiotics, 1987